Oseltamivir for Influenza Lower Respiratory Tract Infection in Children Under One
Status:
Withdrawn
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Currently, there is no treatment for children less than one year of age with influenza
related lower respiratory tract infection that is either considered standard or registered in
any country. This dismal scenario exists even though influenza related LRTI is a significant
illness causing morbidity and mortality, especially in children less than 6 months of age.
Avian influenza has been reported rarely in children less than one.
There are no data in Vietnam and very few data in Thailand on the burden of influenza in
children less than one. This young age group suffers high mortality. Oseltamivir may be
beneficial in such children. This is basis of this trial.